ABSTRACT
Introduction Arboviruses, including Chikungunya (CHIKV), Dengue (DENV), and West Nile (WNV) viruses, are significant viral threats that affect numerous people globally each year. This report explore the prevalence of these viruses in Iran through a systematic review and meta-analysis.
Methods The present survey was performed with a systematic review and meta-analysis method on the seroprevalence of WNV, CHIKV, and DENV using the ELISA test. Based on this, by search in Web of Science, PubMed, Scopus, Cochrane Library, Science Direct, and Google Scholar scientific databases, all relevant published papers were sorted out and reviewed. Power ratification of data was carried out with a random effects model in meta-analysis, meta-regression, I2 index, and Egger test.
Results Twelve published papers between 2000 and 2024 were embodied in this meta-analysis report. The seroprevalence of positive ELISA test for WNV in Iran was estimated at 12.9% (CI=95%: 7.4-18.4), and for CHIKV at 6.2% (CI=95%: 0.6-11.8). Regarding DENV, only two studies were conducted with a zero prevalence in one study, and a seroprevalence of 5.6% in another study.
Conclusion According to these data, WNV, CHIKV, and DENV fevers have been detected in Iran using ELISA test. Considering the seropositivity of WNV and CHIKV, and the finding of these viruses from several provinces, it could be for granted that these two viruses are ubiquitous and DENV fever is sporadic in Iran.
Author Summary Arboviruses, including Chikungunya (CHIKV), Dengue (DENV), and West Nile (WNV), pose significant health threats globally, with increasing infections reported, including in Iran. This report conducts a systematic review and meta-analysis of the seroprevalence of these viruses in Iran through ELISA testing. A total of twelve studies published from 2000 to 2024 were analyzed, revealing a seroprevalence of 12.9% for WNV and 6.2% for CHIKV, while DENV showed a mixed prevalence of 0% in one study and 5.6% in another. The results suggest that WNV and CHIKV are widespread in Iran, whereas DENV appears to be sporadic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* abbasie.ebrahim{at}gmail.com, e_abbasie{at}sums.ac.ir
Data Availability
All data produced in the present work are contained in the manuscript.
